FDA 483 - Finish Line Horse Products, Inc. - February 16, 2023

Finish Line Horse Products Inc., an animal drug manufacturer in Bensenville, IL, was cited for numerous significant deficiencies during an FDA inspection. Repeat observations included vermin infestation and inadequate segregation of rejected components. The firm also lacked critical written procedures and validations for quality control, cleaning, stability testing, and labeling, indicating a systemic failure in GMP compliance.